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1. Introduction 
Modelling and simulation represent well established approaches when analyzing systems’ 
properties, their behaviour, predicting possible scenarios, or estimating potential results or 
responses when influencing the observed system (Cellier, 1991; Cassandras & Lafortune, 
1999; Cellier & Kofman, 2006; D'Inverno & Luck, 2010). Such knowledge organization 
about a given problem can help in its presentation, understanding, explanation and it is 
also frequently used through system design (Matko et al., 1992). 
Modelling and model usage can be classified and/or chosen as methodology regarding 
different criteria which can in addition be interdependent due to important activities needed 
in such situations. Criteria can represent the way of data collecting, their form and degree of 
confidence, model structure and possibilities of model experimentations, the level of 
problem abstraction and its aggregation, the selection of time granulation, etc. One of the 
most important aspect (in spite of the fact that it is often not mentioned) which has to be 
taken into account, is also the goal of modelling which should lead the designer through the 
whole procedure of model development, its interpretation and experimentation. The last 
two facts are very important also for the user of developed model. This is perhaps also one 
of important reasons why very different mathematical approaches and descriptions are 
used, where the disciplines like medicine, pharmacy and the life sciences are no exception 
(Hoppensteadt & Peskin, 2002; Atanasijević-Kunc et al., 2008a; Stahl, 2008; Belič, 2009; 
Arnold 2010). This is true even in the cases where the same problem, like certain disease 
development (diabetes for example) is observed. 
Here the following questions can arise: 
- Which presented or known model regarding certain problem (disease) is the most 
important or relevant one? 
- Should this model be chosen in all situations? 
- Can different modelling structures, descriptions or approaches predict the same or very 
similar results? 
- When there is a need to develop a new approach or problem description? 
- Is it possible to benefit from the usage of several different descriptions of the same 
problem? 
- If the answer to the previous question is positive, it can be important also to find out, how 
different descriptions or models can share their results and/or complement each other? 
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The answers to the first questions are not surprising. Process descriptions should be suitably 
chosen regarding modelling goal(s), modelling phase and other important design factors. As 
indicated in (Stahl, 2008) the investigators should choose the modelling methods that fit the 
defined problem. It means that different descriptions can predict similar or complementary 
results using, for example, different complexity (nonlinear or linear descriptions, high or low 
order descriptions) or different granularity (observation of the whole population, observation 
of an individual patient, observation of dynamical processes on molecular level), different 
aggregation (development of one or several diseases) or perhaps only different model 
presentations are suitable when performing different analysis functions (state space or 
transfer function description, continuous or discrete time description, time or frequency 
domain description, ...). Whenever a new point of view of certain problem is under 
investigation, whenever some new facts or perhaps only different assumptions are taken 
into account, when modelling results are meant to be used by different groups of people 
also a new or improved description can be important. All mentioned facts can be verified 
also when observing different aspects of diabetes mellitus. But, in spite of great diversity of 
results’ description regarding this dangerous chronic disease practically nowhere attention 
is devoted to the idea of their complementary usage. This viewpoint can become especially 
interesting when several factors influencing the problem are taken into account. 
The literature dealing with different aspects of diabetes has become enormous and very 
heterogeneous even in the case when searching is limited to mathematical modelling and 
simulation processes of this disease. Some of them are describing glucose-insulin dynamics 
(Boutayeb & Chetouani 2006; Makroglou et al., 2006; Shianga & Kandeelc 2010), some 
represent epidemiological descriptions of this non communicable disease (Boutayeb et al., 
2004; Boutayeb et al., 2006; Atanasijević-Kunc et al., 2008b), while others describe disease 
development (Eddy & Schlessinger, 2003a; 2003b; Kristöfel, et al., 2007) or the relations to 
risk factors which are in correlation with diabetes development (Brock et al., 2009; MMWR 
2004; Atanasijević-Kunc et al., 2008c). Diabetes can represent by itself or even more intense 
in combination with other possible chronic diseases (dislipidemia, hypertension) or life style 
(smoking, alcohol consumption, inactivity) the risk for developing different cardiovascular 
diseases (Levenson et al., 2002; Atanasijević-Kunc et al., 2008c; 2011). Additional aspect, 
important for modelling structure, can represent social and economical burden of the 
discussed disease and/or treatment efficacy, which is often interpreted through different 
pharmacoeconomical studies (Boutayeb et al., 2004; Tarride et al., 2010; Arnold, 2010; 
Atanasijević-Kunc et al., 2011), where cost-effectiveness analysis and cost – utility analysis 
provide a basic comparison of different treatment policies or drug efficacy. All mentioned 
situations can be interpreted as open or closed – loop problems (Atanasijević-Kunc et al., 
2008c; 2011; Bellazzi, 2001; Lam, 2002; Makroglou, 2006), where especially in the second case 
the analysis should take into account stability and sensitivity of system behaviour. 
The modelling and simulation approach aims to indicate, use and/or develop mathematical 
problem presentations which can be used for the evaluation of the burden of diabetes type 2 
(D2) mellitus and correlated processes which can contribute to disease development or can 
represent the source of expenses (direct and/or indirect). This burden is not important only 
from the economical but also from the social point of view due to the possible severe health 
complications which usually essentially influence the quality of life. 
For the evaluation of mentioned disease burdens regarding certain population it is of most 
importance first to estimate the number of patients and the treatment expenses. In addition 
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also the treatment efficacy can be taken into account which can compare different treatment 
strategies and/or their influence to further complications development. In addition, of 
course, also the reasons which influence D2 development can be taken into account, as 
usually the prevention offers the most effective positive influence to economical and social 
situation. 
This chapter is organized in the following manner. In the next session some modelling 
structures are indicated which have been used for modelling purposes of D2 presentation. 
Special attention is devoted to the possibilities of coexistence of different modelling 
descriptions. Simulation results are illustrated in session 3, where also some of expenses, 
related to observed patients are estimated. The work ends with conclusion remarks and 
some ideas for future investigations. It is also important to mention that all presented results 
were realized using Matlab (Matlab, 2005) with Simulink (Simulink, 2005). 
2. Modelling structures 
One of the simplest presentation which is describing the D2 population, two – compartment 
linear model, is illustrated in Fig. 1 (Boutayeb et al., 2004). Input signal u(t) represents the 
incidence of D2, while C(t) and D(t) are the numbers of D2 patients with and without 
complications, respectively. It is expected that patients with D2 are developing 
complications with k1D(t) rate, in the compartment C(t) they can recover and therefore 
return to D(t) compartment (with k2C(t) rate), they can die due to natural causes (with c1C(t) 
rate) or due to severe complications (with c2C(t) rate), and they can also become seriously 
disabled (with c3C(t) rate). The authors have suggested stability analysis with respect to 
model parameters and numerical problem solving. In this simple description the population 
in each compartment is observed as a homogeneous set of patients and it is expected that 
parameters are time – independent. Important aspects as for example patients’ age, life style, 
body mass, simultaneous joint diseases and similar are not presented explicitly, they can 
only influence (through the identification process) the values of model parameters. Further 
extension to nonlinear description was proposed in (Boutayeb et al., 2006), but basic 
viewpoint remains unchanged. 
Far more complex dynamical nonlinear model, as schematically presented in Fig. 2, was 
originally developed and tuned for the USA (Homer et al., 2004) and later on also adapted 
with some improvements to the population of Austria (Kristöfel et al., 2007). In comparison 
to the structure in Fig. 1 this one recognises also the patients with pre-diabetes, not only 
those where D2 is completely developed, while both groups can be diagnosed or not. So 
additional four compartments are needed, while special attention was devoted also to the 
transition flows, which are dependent on a great number of important factors and ratios, 
like population age, obesity, activity and similar. One difference in comparison to model in 
Fig. 1 is also the interpretation regarding patients with complications, as they can’t reach the 
state without complications anymore.  
It is important to mention that authors have in this last case devoted detailed attention to the 
validation and verification of proposed models using extensive data, which are in general 
not available for all countries. Due to model complexity sensitivity and stability analysis 
demanded the introduction of expected range of variables’ changes and simulation testing. 
When economical burden of disease treatment and/or treatment efficacy is of interest in 
many cases the so called decision modelling techniques are used (Arnold, 2010). Decision 
trees have been for more than forty years the most common and simplest formalism, 
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comprising choices, chances, and outcomes. For the similar situation as in previous two 
presentations the idea is indicated in Fig. 3.  
 
 
 
Fig. 1. Two - compartment modelling structure 
 
 
 
Fig. 2. System dynamics model for the diabetes prevalence 
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Fig. 3. Decision tree modelling structure 
Such problem presentations are static and they don’t enable the observation of patients’ 
history, as in the previously mentioned cases. In problems that lead to long – term 
differences in outcome such presentation can be insufficient. One way to avoid (at least 
partly) this drawback is to use the description in the form of the so called Markov process 
(Stahl, 2008; Shih, 2007) or to extend the decision tree to include also Markov processes, for 
example at the outcome node as illustrated in Fig. 4 (Arnold, 2010). The advantages of such 
presentations are that they are relatively simple, frequently used and therefore also well 
accepted as abstract problem presentation. But there are also two main limitations (Stahl, 
2008; Arnold, 2010). State transitions can only occur at the end of a cycle, which can create 
some biases, and Markov cycle time may force the analyst to make simplifying assumptions 
regarding transition probabilities. 
Economical burden regarding the situation inside the observed population was investigated 
also by (Briggs & Sculpher, 1998; Atanasijević-Kunc et al., 2008b; 2008c; 2011). When 
summarizing the mentioned results the modelling structure can be presented as illustrated 
in Fig. 5. The problem presentation and design is separated into three main phases. Through 
the first phase risk factors and chronic diseases are described in the form of prevalence 
distribution regarding patients’ age, in the second design phase also the prevalence of 
different complications are added, where among the patients with more problems indicated 
in the first phase or in the case where chronic diseases were not correspondingly treated, 
also the development of complications was more frequent. Input signal to the first phase is 
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unity step indicating the start of problem observation, namely at the birth. The results from 
the first and the second phase are entering the third phase together with input signals u2(t) 
and u3(t). Input signal u2(t) provides the information regarding the number of people in the 
observed population with respect to their age, while with u3(t) also the prices for needed 
treatment are defined. Combining the signal u2(t) with calculated prevalence distribution 
enables the definition of patients’ number in the observed population, and using the prices 
from u3(t) also the economical burden can be calculated. 
 
 
 
 
 
Fig. 4. Usage of Markov processes in decision tree structure 
Presented structure gives very good insight how patients are distributed regarding their age 
and also how this influences the economical burden of observed population. In the case of 
similar disease distribution only demographic data can be changed and perhaps (if 
essentially different also) prices and model gives the estimation of patients’ number or 
treatment economical burden for another country or group of people. This approach is 
therefore especially interesting for the countries or areas for which national diseases 
registers are not available. But, the drawback of this mathematical presentation is, that it is 
very difficult to identify the influence on population, which is the result of some actions 
realized on only one part of the population where also the transient response due to 
dynamical system properties should be taken into account. To indicate how to overcome 
this problem let’s present only one part of the situation from Fig. 5 and from a slightly 
different view point. The idea is illustrated in Fig. 6 taking into account also the possibility 
of coexistence of different dynamical processes descriptions. 
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Fig. 5. Diseases prevalence, number of patients and expenses presentation 
Here D2 is a disease of the third level due to the fact that on one side risky and/or unhealthy 
life style (population status observed in the second level of the structure) can influence the 
development of this chronic disease, but D2, as already mentioned, can also contribute to 
development of different health complications (presented at the fourth level of the proposed 
structure). At the second level two important problems, namely activity or inactivity and 
obesity are taken into account, which are two most important problems leading to D2 (Defay 
et al., 2001; DPPRSG, 2002; Kriska et al., 2003; Mokdad et al., 2003; ADA, 2007;). 
D2 is usually preceded by a pre-diabetes (“a metabolic condition characterised by insulin 
resistance and primary or secondary beta cell dysfunction which increases the risk of 
developing type 2 diabetes and cardiovascular disease” (Tuomilehto  et al., 2001; Valensi et 
al., 2005). It is extremely common, especially in elder population (40+). Efficient 
pharmacological therapies are known, which can be very efficient together with lifestyle 
interventions in prevention or delayed D2 development. 
As mentioned processes are observed regarding certain population, an important influence 
to overall situation can contribute also demographic changes which are influencing the 
system’s states at the first level. 
Expenses are here presented as a static property, but can be in the future extensions 
reformulated to indicate the results of economical and financial flows. 
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Fig. 6. Limited sub-problem with dynamic processes at different levels 
3. Simulation results 
Modelling procedure of the structure indicated in Fig. 6 has started by observing the 
available information regarding the prevalence of population activity/inactivity and obesity 
as they are closely related to the probability of developing D2. It is important to mention 
that statistical data differ slightly for different world areas (Berghöfer et al., 2008; WHO, 
2011a), but data for larger countries seem to be reliable also for the countries with 
comparable demographic, economic and social situation. 
As very well known, activity has a significant direct influence to body weight and especially 
to adequate body mass maintainance, but is important also by itself as a prevention 
regarding the development of D2 (Defay, 2001; Brock, 2009). In adult population to the 
group of high active are classified those, who are active 30 minutes or more on at least five 
days a week, medium active are those, who are active 30 minutes or more 1 to 4 days a 
week, other are low active. In children the following division was adopted: high 
(recommended): 60 minutes or more on all 7 days per week; medium: 30–59 minutes on all 7 
days per week; low: lower level of activity. Usually activity in men and women slightly 
differ (men and boys are slightly more active), but average data, which were used for 
modelling purposes, are summarized in Table 1 (British Heart Foundation Statistics 
Website, 2008). 
Overweight and obesity are defined as abnormal or excessive fat accumulation that may 
impair health. The number of these people is constantly increasing and consequently the 
World Health Organization (WHO, 2000) has recognized obesity being a disease too and as 
such it deserves far more attention. It is mainly a consequence of unbalance between energy 
intake and energy expenditure in each individual. 
For adults, overweight and obesity ranges are determined by using weight and height to 
calculate a number called “body mass index” (BMI). It is defined as the weight in kilograms 
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divided by the square of the height in meters (kg/m2). BMI is used because, for most people, 
it correlates with their amount of body fat. However, it should be considered as a rough 
guide because it may not correspond to the same degree of fatness in different individuals. 
WHO defines "overweight" as a BMI equal to or more than 25, and "obesity" as a BMI equal 
to or more than 30 (WHO, 2011b). WHO’s latest projections indicate that globally in 2005 
approximately 1.6 billion adults (age 15+) were overweight and at least 400 million adults 
were obese. Children were defined as overweight or obese using the 85th and 95th percentiles 
of the reference curves. At least 20 million children under the age of 5 years were 
overweight globally in 2005. Once considered a problem only in high-income countries, 
overweight and obesity are now dramatically rising in low- and middle-income countries, 
particularly in urban settings. The prevalence of obesity differs from country to country and 
is also different regarding men and women. An average situation, which can be taken into 
account for most European countries, is presented in Table 2 (British Heart Foundation 
Statistics Website, 2010). 
From data given in Tables 1 and 2 it is clear that activity or inactivity, as well as overweight 
and obesity can, regarding the whole observed population, be interpreted as dynamical 
processes where age of people is represented as independent variable. 
In Fig. 7 the model response is illustrated which shows that activity is decreasing through 
the whole life time and is becoming especially intensive after the age of 40. When activity is 
defined also the prevalence of inactive are known, as is indicated in Fig. 8. The dynamical 
structure which gives the responses presented in Figs. 7 and 8 was identified so that good 
matching was achieved with data in Table 1 (dynamical nonlinear model of 11th order). 
 
age 
 [years] 
0 1 2 3 4 5 6 7 
average 
 [%] 
70 69 68.5 69 70 62 62.5 69 
age 
 [years] 
8 9 10 11 12 13 14 15 
average 
 [%] 
68.5 64.5 64.5 64 64.5 64.5 58.5 56.5 
age 
 [years] 
16-24 25-34 35-44 45-54 55-64 65-74 75+  
average 
[%] 
43 44 40.5 36 31 18.5 6.5  
Table 1. Prevalence of high active population 
 
age [years] 2-15 16-34 35-54 55-74 75+ 
average prevalence: 
25=<BMI<30 [%] 
13.5 27 39 41.5 37.5 
average prevalence: 
BMI=>30 [%] 
16 19 33.5 31.5 22.5 
average prevalence: 
BMI=>25 [%] 
29.5 46 72.5 73 60 
Table 2. Prevalence of overweight (25=<BMI<30) and obese population (BMI=>30) 
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It is important to note that such representation enables the extension of decision tree 
formalism to comprise also a time component, namely the age of observed people (and/or 
patients). This time component is of crucial importance also regarding the prevalence of 
great number of chronic diseases and corresponding consequences. Another advantage is 
that when certain population is observed these responses can be combined with 
demographic data to evaluate the number of observed people. 
In Fig. 9 the result of the last count of the population in Slovenia in 2003 is illustrated. When 
combined with the prevalence of activity in Fig. 7 it becomes clear that in Slovenia around 
780 000 people or 39% are active, while other 61% do not match this criteria. Distribution of 
the number of active people regarding their age is presented in Fig. 10. 
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Fig. 7. Prevalence of activity 
Two output signals from the block “activity” (see Fig. 6) are entering the block “obesity”. 
For modelling purposes the information from Table 2 was used. It is clear that the ratio 
between overweight and obese population is slightly changing through the life time, but as 
these changes are not very distinctive the assumption that it is equal to 1.33 (average value 
from Table 2) is taken into account. 
It is also very well known that active life style has very good influence also to body mass 
and in contrary people who are obese are inclined to inactivity, but there is practically no 
quantitative data available regarding the statistical correlation on the population level 
among these two variables. The interesting exception represents the paper of Brock (Brock et 
al, 2009), where the association between insufficiently physically active and the prevalence 
of obesity is described for the USA in the form of linear regression model. Testing this 
description in comparison to information from Table 2 and presented activity response 
showed that it is expected the prevalence of obesity to be slightly lower in EU countries. 
Further nonlinearity can be presumed which can mainly be the reason of the fact that 
activity is essentially decreasing especially after the age of 45 (see Fig. 7).  
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Fig. 8. Prevalence of activity and inactivity in observed population illustrated through 
decision tree 
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Fig. 9. Number of people in Slovenia 
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Fig. 10. Number of active people in Slovenia 
Taking into account all mentioned data the mathematical model (11th order with time 
delays) of overweight and obese population was identified and responses are presented in 
Fig. 11. It is also possible to differ among overweight and obese taking into account 
mentioned ratio. 
When prevalence functions are defined also the number of these people can be calculated (Fig. 
12). Regarding the presented model in Slovenia live over 1 million people who have BMI equal 
to or greater than 25 or with other words almost 55% of population have higher body mass as 
recommended. Among these people around 300 000 are active while others are not. 
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Fig. 11. Prevalence of population with BMI=>25 
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Both, inactivity and obesity are very important regarding the development of D2 (Valensi et 
al., 2005). It was discovered that most adults (85.4 - 86% in average) with diagnosed diabetes 
were overweight or obese (MMWR, 2004), 52% were obese, and 8.1% had morbid obesity 
(Daousi, 2006). Before this chronic disease is fully developed patients have a pre-diabetes 
which in general significantly differ from D2 regarding the fact that when strict life change 
is adopted taking into account corresponding diet and activity, sometimes complemented 
by drug treatment, patients can return to normal state. Sometimes this transition is (for 
example due to long lasting pre-diabetes) not possible, but in such situations D2 
development is in most cases significantly postponed. Pre-diabetes is not a true disease but 
can be interpreted as a serious risk factor for developing D2 and cardiovascular diseases. 
Over 30% of people with pre-diabetes develop D2 within 5 years (Valensi, 2005). The 
average conversion rate was estimated at 5.8% per year with wide variations which depend 
on differences in age, BMI, ethnicity, etc.. It is very important to accent that several well-
designed randomized controlled trials (Valensi, 2005) have been reported that categorically 
confirm the benefits of interventions in pre-diabetes. Standardized diet with reduced food 
intake, increased physical activity and sometimes also additional drug treatment can reduce 
the incidence of D2 for almost 60% (in mentioned studies from 25% to 58%). But, it is 
important to point out that intensive lifestyle modification was nearly twice as effective in 
preventing D2. It is therefore evident that active management of pre-diabetes can be very 
effective in preventing the progression of diabetes. 
For modelling purposes the information given in Tables 3 (Narayanappa et al., 2011; Li, et 
al., 2009; NDS, 2011; Valensi et al., 2005) and 4 (Behl et al., 2004) was taken into account. 
Again the average data between men and women are presented. 
 
 
 
0 10 20 30 40 50 60 70 80 90 100
0
0.5
1
1.5
2
2.5
x 10
4
age[yeas]
n
u
m
b
e
r 
o
f 
p
e
o
p
le
BMI=>25
active
inactive
 
 
 
Fig. 12. Number of people in Slovenia with BMI=>25 (active and inactive) 
www.intechopen.com
 
Topics in the Prevention, Treatment and Complications of Type 2 Diabetes 
 
16
age 
[years] 
5-11 12-19 20+ 40-75 65+ 
average 
prevalence 
[%] 
3.7 16.1 35 40 50 
Table 3. Prevalence of pre-diabetes 
 
age 
[years] 
25-34 35-44 45-54 55-64 65+ 
average 
prevalence 
[%] 
3.5 4.2 8.9 15.5 19 
Table 4. Prevalence of diabetes type 2 
In Fig. 13 model responses are given regarding pre-diabetes (16th order model with time 
delays) and D2 (5th order with time delays), what further enable the calculation of observed 
patients with respect to their age, what shows Fig. 14. It can be concluded that in Slovenia 
live around 611 000 patients with pre-diabetes, or with other words, approximately 30% of 
the population is in such state. In addition almost 144 000 are D2-patients, or over 7% have 
developed this serious chronic disease. Among this group of patients 85.7% are overweight 
or even obese. 
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Fig. 13. Prevalence of pre-diabetes and D2 
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Fig. 14. Number of patients with pre-diabetes and D2 in Slovenia 
In this design phase also some of expenses needed for observed patients can be indicated. 
For the population with higher mass it is possible to find out that a great majority of these 
people would like to loose their overweight. Some of them are experimenting with different 
diets, around 20% of adult population (from 18 to 60) also use drugs, and around 5% from 
the age window of 40 to 60 use the help of medical experts. In some special cases also 
surgical help is needed. In Slovenia in average around 100 such surgical operations per year 
can be expected. More and more frequent are also cosmetic surgical operations, but were not 
taken into account here as they are mainly performed in private institutions and data are not 
available. 
It was estimated, that for one overweight or obese patient the year price for drugs is €447.96, 
what represents an economic burden of €66.88 million per year (for 20% of adult population 
between 18 to 60). As year treatment by medical expert represents economical burden of 
around €3000 for this group additional €63.4 million is used (for 5% from the age window of 
40 to 60). Prices for surgical operations differ drastically. In Slovenia for such intervention 
€7200 is needed for one patient or €720 000 per year for the whole country. All together this 
represents €131 million per year of direct costs or in average around €130 each year for each 
from the group of obese or overweight persons. 
An average year treatment price for one D2 patient was estimated to be €355 (Atanasijević-
Kunc et al., 2008c) (general practitioner: 4 times / year, laboratory: 2 times / year, drugs), 
representing economical burden of over €51 million per year. It is important to observe that 
the maximum number of these patients can be expected inside the age window of 55 to 75. 
As population in Slovenia, similar to other EU countries, is getting older, in the future 
decades this burden can become even more serious. 
To estimate such population changes mathematical model was developed taking into 
account average statistical parameters using data (fertility, mortality and migrations) from 
2004 to 2007 as presented by Statistical Office of the Republic of Slovenia (SORS, 2011). 
Fertility was calculated regarding the number of people in the age window from 18 to 45. It 
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was estimated that each year 2.2715% newborns are expected regarding the mentioned 
group of people. The realized prediction starts in 2003 and illustrates the expectations till the 
year 2052. The situation is illustrated in Fig. 15. An important observation from this figure is 
that the number of people after the age of 60 is expected to increase while the younger 
population, including also the majority of working people, is diminished. Combination of 
modelling results from Fig. 15 and the prevalence of D2 model is shown in Fig. 16.  
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Fig. 15. Number of people in Slovenia from 2003 to 2052 
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Fig. 16. Number of D2 patients from 2003 to 2052 
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The number of D2 patients in younger population is expected to decrease as the number of 
younger population is also decreasing, but after the age of 60 the number of D2 patients is 
essentially higher. The ratio between the number of D2 patients and the number of active 
people (people between 20 and 60) in 2003 equals 0.1208, while in 2052 it is expected to rise 
to 0.2036. This means that for active population only regarding D2 patients the economic 
burden is expected to increase for 68.5% if the prevalence of this disease remains 
unchanged.  
Here it is important to point out also the following additional facts: 
- As revealed in (NDS, 2011) the average medical expenditures for the people with 
diagnosed D2 are 2.3 times higher than that for the people without D2. 
- The prevalence of several other chronic diseases and different complications are higher 
among older population (Atanasijević-Kunc et al., 2008a, 2008b, 2008c). 
Therefore it would be of great importance to indicate and evaluate some solutions which 
would decrease this enormous social and economical burden. 
The increase of activity is, regarding medical recommendation, the first step which can 
represent an improvement in desired direction, and the second is of course body mass 
reduction. To estimate the interdependence of mentioned variables in a quantitative manner 
two-compartment mathematical model was used (Chow & Hall, 2008), enabling to differ 
among fat-free body mass (ffm) and fat mass (fm). Equation for daily energy balance is: 
      eb t ei t ee t   (1) 
where ei(t) represents daily energy intake and ee(t) daily energy expenditure in kcal. Energy 
intake depends on food and its caloric value: 
        1 2 3ei t k ci t k fi t k pi t    (2) 
ci(t) indicating carbohydrate intake, fi(t) fat intake and pi(t) protein intake while constants ki 
are: k1=4kcal/gram, k2=9kcal/gram, k3=4 kcal/gram. It is recommended that protein intake 
represents 20-30%, fat intake 15-20% and carbohydrate intake 55-60% of daily food intake. 
Daily energy expenditure is calculated as follows: 
        ee t tef t pa t rmr t    (3) 
where tef(t) is thermic effect of feeding which usually ranges from 7 to 15% of the total 
energy intake (11% in our case), pa(t) represents energy spent on physical activity and rmr(t) 
is the so called resting metabolic rate. It refers to the energy needed to maintain basic 
physiological processes. It represents a substantial percentage (45-70%) of energy 
expenditure for the typical individual (HER, 2001). It mainly depends on ffm(t) and was 
approximated with: 
    500 22rmr t ffm t   (4) 
The daily energy balance eb(t) is partitioned into one of two compartments for fat mass and 
for fat-free mass: 
       1
fm
r t eb tdfm t
dt ρ
  (5) 
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     
ffm
dffm t r t eb t
dt ρ  (6) 
where r(t) ratio is the parameter that assigns a percentage of the imbalance denoted by eb(t) 
to the compartments fat mass and fat-free mass, respectively (Dugdale & Payne, 1977): 
     ;     10.4
ffm
fm
ρK
r t K
K fm t ρ   (7) 
1800 /
9400 /
ffm
fm
ρ kcal kg
ρ kcal kg

  
It is important to mention that also more precise (and complex) mathematical models 
describing the influence of eating and physical activity to body mass exist. But in our case 
the goal was mainly to present the interdependence of different models and information 
which can be shared to obtain better insight into population behaviour what is also the 
reason why in this modelling step only an average person (between men and women) was 
taken into account. From the average height (1.72m regarding 11 European countries) and 
average BMI=32 also the average mass of this person is estimated to be 94.7kg. Regarding 
medical recommendations such person should loose around 30kg to satisfy BMI=22 in the 
middle of desired BMI interval. The initial fat mass was estimated from the regression 
equations (Jackson et al., 2002): fm(0)=34.7 kg. 
Model response is given in Fig. 17 for observation time of 10 years. During the first year (365 
days) energy intake is equal to energy expenditure (2460kcal) (for control purposes) and 
therefore the body mass remains unchanged. After the first year physical activity is 
increased from 370kcal per day (representing minimal physical activity) for 210 kcal per 
day. This energy expenditure can be realized by a half an hour walk, but without the 
increase of energy intake. Such minimal increase of activity, which is in general suitable also 
for obese persons, would change in three years BMI to 25. 
In our case however, at the beginning of the third year of observation also the energy 
intake is decreased for 300 kcal per day, but only for one year. In this way desired range 
of BMI is reached during the second year as presented in Fig. 17. If the person remains 
active for half an hour per day he-she is reaching desired mass at the end of the third 
year. 
What direct changes could such a regime of activity and diet represent for observed 
population and why the problems are expected in practice? 
Let’s take into account the following assumptions. 80% of obese and inactive people 
between the age of 20 to 50 are motivated to undertake the presented regime of increased 
activity and diet. With this they are immediately transferred into the group of active 
population, where they remain. After two years of activity they are also transferred out 
from obese population and they remain in the group of people with healthy body mass. 
Each year also 80% of 20 years old obese and inactive are motivated to join the motivated 
group. 
The consequences of life – lasting increased activity together with corresponding diet are 
shown in Figs. 18 to 20. The increased number of active population (Fig. 18) would together 
with proposed diet slowly changing the number of overweight and obese people (Fig. 19).   
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Fig. 17. BMI changing in an average person 
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Fig. 18. Activity is increasing 
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Fig. 19. Number of overweight and obese patients is decreasing 
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Fig. 20. Number of D2 patients is decreasing 
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The consequence would be that among this group of patients from pre-diabetes only 50% 
would develop D2, while other would return to the population with healthy body mass and 
without D2 (Fig 20). 
In this way the number of obese and overweight people would be decreased for over 53% 
and the number of D2 patients for 35%. In the same proportion also the corresponding 
expenses would be reduced. 
The proposed strategy has one important deficiency, namely the lack of patients’ motivation 
and discipline as the success is completely dependent on these two important factors.  
Therefore our further goal is to extend the presented model with motivation aspects and 
expenses needed for its stimulation. 
4. Conclusion 
Four-level mathematical description structure is proposed which can be efficiently used 
for the estimation of the number of observed patients, the distribution regarding their age 
and for the estimation of their economical burden. It can comprise different mathematical 
descriptions important for observed processes. In our case it consists of dynamical 
decision tree describing the prevalence of population activity and inacivity, overweight 
and obesity, pre-diabetes and diabetes type 2. In combination with dynamical population 
model predicting the number of people, two-compartment dynamical model for 
estimation of body mass changes and evaluated treatment expenses also the number of 
observed patients and treatment burden were calculated for Slovenia. As similar results 
can be expected in the countries with comparable social and economical situation (the 
great majoity of EU countries), the following can be concluded for the population of one 
million people: 
 over 60% are inacive, 
 only 45% have body mass in normal range, 
 overweight and obese patients spend around €65.5 million per year for body mass 
reduction, 
 30% of people has pre-diabetes, 
 over 7% have developed diabetes type 2, 
 direct tratment expenses for D2 patients are around €25.5 million, 
 essential savings could be expected with minimal life-style changes, 
 in this way the number of obese and overweight people could be decreased for over 
53% and the number of D2 patients for over 35%. 
It is obvious that motivation is the most important obstacle in achieving the efficient 
improvement in reduction of D2 patients and corresponding economical burden. Therefore 
our future interest will be directed in developing corresponding mathematical model to 
complement the presented structure and to indicate the potentially important further 
activities. 
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